ASPH and breast carcinoma: In addition, the inhibition of ASPH suppresses the migration of ASPH-overexpressing MDA-MB-231 cells in vitro [57], suggesting that ASPH might be a potential target for the treatment of brain metastasis in HER2-positive breast cancer as well.